ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2008

Oct 29, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-10-28

Reporting Person: Clendeninn Neil James (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-10-28	stock option (right to buy)	$2.69	A	17000	Acquired	2015-10-28	Common Stock (17000)	Direct

Footnotes

F1: 4,250 options are exercisable on each of January 28, April 28, July 27 and October 28, 2009.